The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Sagent Pharmaceuticals Inc

  • Contact Person: Ed Schipp
  • Contact Phone: 847-908-1652
  • Contact Email: eschipp@sagentpharma.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • Foreign Owned and Located
  • For Profit Organization
  • Manufacturer of Goods
  • Industries Served: Medicinal and Botanical Manufacturing, Pharmaceutical Preparation Manufacturing, In-Vitro Diagnostic Substance Manufacturing, Biological Product (except Diagnostic) Manufacturing
  • Product Areas: ACCOUNTING SERVICES, SUPPORT- MANAGEMENT: ACCOUNTING, SUPPORT- MANAGEMENT: AUDITING, AUDITING SERVICES

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $44,954 - Thursday the 6th of August 2015
    Centers For Disease Control And Prevention
    DEPT OF HHS/CENTERS FOR DISEASE CONTROL
    SAGENT PHARMA - TASK ORDER 0001 - YEAR 1 VMI
  • $3,846 - Friday the 1st of June 2012
    Veterans Affairs Department
    69D-NETWORK CONTRACT OFFICE 12
    CIPROFLOXACIN
  • $181,705 - Wednesday the 25th of July 2012
    Veterans Affairs Department
    69D-NETWORK CONTRACT OFFICE 12
    CIPROFLOZACIN 2MG 24X200 ML
  • $110,561 - Tuesday the 14th of August 2012
    Veterans Affairs Department
    69D-NETWORK CONTRACT OFFICE 12
    CIPORFLAXIN FOR MULTIPLE STATIONS

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.